📰 Augmedix Prep News
Augmedix Prep News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Augmedix Prep. Real-time updates on events, politics, business and more.
May 28, 2024
Millrace Asset Group Inc. decreased its holdings in shares of Augmedix, Inc. (NASDAQ:AUGX – Free Report) by 40.1% in the 4th quarter, HoldingsChannel reports. The firm owned 203,087 shares of the company’s stock after selling 135,745 shares during the period. Millrace Asset Group Inc.’s holdings in Augmedix were worth $1,188,000 as of its most recent […]
May 28, 2024
Millrace Asset Group Inc. trimmed its position in Augmedix, Inc. (NASDAQ:AUGX – Free Report) by 40.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 203,087 shares of the company’s stock after selling 135,745 shares during the quarter. Millrace Asset Group Inc. owned approximately […]
May 26, 2024
Augmedix (NASDAQ:AUGX – Get Free Report) and Micromobility.com (NASDAQ:MCOM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Volatility and Risk Augmedix has a beta of 0.03, […]
May 18, 2024
Evercore ISI lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from an outperform rating to an inline rating in a report issued on Tuesday, MarketBeat reports. They currently have $1.50 price objective on the stock, down from their prior price objective of $5.00. Other research analysts also recently issued reports about the stock. Maxim Group […]
May 18, 2024
Maxim Group lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from a buy rating to a hold rating in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has $5.00 target price on the stock. A number of other equities analysts also recently commented on AUGX. B. Riley started coverage on shares of […]
April 12, 2024
Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 24,778 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $3.93, for a total value of $97,377.54. Following the completion of the sale, the insider now owns 3,000 shares of the company’s […]
April 10, 2024
Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 37,780 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $3.97, for a total value of $149,986.60. Following the transaction, the insider now owns 3,000 shares in the company, valued […]
April 9, 2024
Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]
April 9, 2024
Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]
April 9, 2024
Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Tuesday, Benzinga reports. The brokerage presently has a $5.00 target price on the stock, up from their previous target price of $4.50. Evercore ISI’s price objective indicates […]